Wemedoo
The Go-to Clinical Information Specialists

Throughout the clinical trial industry, a number of challenges curb an organisation’s ability to reach its goals. More common ones, and the more difficult among them, are a lack of time, poor data standardisation, loss of data quality due to multiple data transfers, use of disparate systems, and an over reliance on manual tasks. To compete, sponsors and CROs need flexibility, agility, and more efficient clinical trial information management systems. In response to such challenges faced by many in the industry, Switzerland-based Wemedoo dedicates all its efforts towards streamlining clinical research processes and bolstering productivity for all players in the international biomedical marketplace.

The following interaction between Pharma Tech Outlook Europe and Dr. Nikola Cihoric, founder of Wemedoo, is an interview to understand two things: Wemedoo, and its innovative clinical trial solutions.

How would you describe Wemedoo? What makes the company one in a million?

We are clinical information specialists. Our vision is to break down barriers between sponsors, CROs, healthcare institutions, and academia, to leverage medical data to drive the smart evolution of medicine. Our expertise is focused on facilitating data collection, preserving clinical data integrity, deriving information from the acquired data, and turning it into medical knowledge. The result is faster time-to-market and improvement of patient outcomes.

Our unique interdisciplinary approach combines new technologies and clinical research process expertise into powerful and easy to use system architectures. We have shifted the paradigm in the digital era of clinical research. Clinical data interoperability is at our core, simultaneously enabling data standardization, reusability, and exchange to ensure continuing improvements in patient outcomes. The use of our technology and interdisciplinary expertise creates significant benefits to our clients and helps them overcome today’s prominent challenges. It has resulted in lean processes, dramatic increases in data quality, improved timelines, and cost reductions. We provide our complete and continuous support, always striving to move our partners ahead of the competition.

What solution does Wemedoo help customers move ahead of the competition?

We offer highly customised expert services and clinical trial software solutions. The application of our expertise starts at the study design phase and follows through to final statistical analysis and reporting. What separates Wemedoo is our commitment to interoperability and data standards out of the box.

For our clients we develop a standardized system of data governance that is necessary for their clinical trials. We carefully listen to their needs and requirements, not only for the trial they are currently running, but on their organizational level. It then becomes easy to follow through with rapid eCRF implementation and data discrepancy check specification development. In that manner we ultimately accelerate their timelines and provide them with standardized reusable data. This approach enables meta-analyses of multiple clinical trial datasets and simple data aggregation that results in overarching knowledge generation that is, for other organizations, at best extremely difficult and at worst impossible.

Clinical management and the associated processes are performed within our own Oomnia Suite of integrated software solutions, including electronic data capture (EDC) and clinical trial management (CTM) systems, randomization and trial supply management (RTSM), and electronic patient-reported outcome (ePRO).

Our vision is to break down barriers between sponsors, CROs, healthcare institutions, and academia, to leverage medical data to drive the smart evolution of medicine

The beauty of having comprehensive clinical data approach that includes subject matter experts and our software team is that we can carefully take care of all our clients’ needs and be acutely responsive to changes therein.

With Oomnia, our clients can access multiple trials with a single click. They benefit from the resourcefulness of standardised databases, where the functionalities enable users to connect disparate datasets and aggregated analysis across multiple trials. Our clients gain meaningful insights during the entire clinical trial life cycle, minimise repetitive tasks, and can adapt the system to suit their trial-specific needs at any given time. The incomparable flexibility of the system, and our agile approach, are highly valued by our partners and clients.

How does Wemedoo onboard its clients? Is there a case study that best summarises the efficiency of your offerings?

Each client has different needs and challenges, and our onboarding process is tailored specifically to each client. For example, developing companies require a more consultative approach. We help them wade through the complicated processes and trial setup as it pertains to data management and information flow with our expertise, high-quality standards, and a system that is fully compliant with all applicable rules and regulations. It is our responsibility to assist them by proactively identifying and preventing possible issues. It is possible that they require assistance and consultation regarding study design, endpoints, and outcomes. On the other hand, there are established clients with complex study designs that are heavily burdened with time- and cost-intensive data curation processes. These are clients running multinational trials with many moving parts. Within one study, they need centralized randomization and drug supply management and setup of notifications for users and/ or roles while using local laboratories where it is necessary to set up multiple reference ranges and then standardize and normalize the results at the end. Additionally, they may want to aggregate data and information across multiple concurrent or sequential trials. These types of specificities require individual tailor made approaches and an understanding of business processes. I think, in the end, it is the team that matters most. Our partners endorse our out-of-the-box thinkers who can tackle any challenge with precision and ingenuity.

In terms of efficiency, I have a great anecdote. We are currently conducting a trial in our system where we have set up the data collection and management tools for a first time for a client. Their global head of clinical operations called to tell us that this was the first time in their 20 years of performing clinical trials that site staff did not need additional instruction when using an EDC system, nor did they need help in navigating the data entry steps in a relatively complex eCRF. They have now almost completed the trial and not once have they had to contact us for support. This is a great accomplishment and speaks volumes of how our user friendly systems and processes increase clinical trial efficiency.

What does the future hold for Wemedoo?

We see the future of Wemedoo, and clinical research, in the development and establishment of an integrated system of expertise and interoperable software solutions that enables standardized collection, aggregation, exchange, analysis, and dissemination of clinical research data and information. We are actively pursuing decentralized trials and have established a world-wide network of collaborators for RWD collection / electronic healthcare record (EHR) integration.

We believe that the distinctions between clinical research data sources will slowly fall to the wayside and become irrelevant and the clinical trial industry will be left with a single truth. Clinical data must be integrated in a standardized fashion from all sources into one coherent system. Wemedoo leads the way to this future.